Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell Tribe Technology (TRYB) by Steve Moore in ShareProphets
- Sell Seeing Machines Ltd. NPV (DI) (SEE) by Steve Moore in ShareProphets
- Sell Quiz (QUIZ) by Steve Moore in ShareProphets
- Buy Croda International (CRDA) by Tom Winnifrith in ShareProphets
- Buy British American Tobacco (BATS) by Mark David Hartley in The Motley Fool
- Buy Diageo (DGE) by Stephen Wright in The Motley Fool
- Buy Taylor Wimpey (TW.) by Harvey Jones in The Motley Fool
- Avoid Inspects Group (SPEC) by Steve Moore in ShareProphets
- Buy Zotefoams (ZTF) by Hot Stock Rockets in ShareProphets
- Neutral Ceres Power Holdings (CWR) by Goldman Sachs
- Sell Bunzl (BNZL) by Goldman Sachs
- Buy Anglo American (AAL) by Stephen Wright in The Motley Fool
- Hold AstraZeneca (AZN) by Ben McPoland in The Motley Fool
- Hold BAE Systems (BA.) by Ben McPoland in The Motley Fool
- Buy Land Securities Group (LAND) by Robert Stephens (Telegraph) in The Telegraph - Questor
- Buy Greggs (GRG) by Ben McPoland in The Motley Fool
- Sell Inspired (INSE) by Steve Moore in ShareProphets
- Neutral Schroders (SDR) by JP Morgan
- Sell Jaywing (JWNG) by Steve Moore in ShareProphets
- Sell Jubilee Metals Group (JLP) by Tom Winnifrith in ShareProphets
Convatec Group (CTEC) Share Price
Health Care Sector
NOTE: This is based on 284 open tips for Convatec Group (CTEC)
| Latest Bid : 220.80p | Latest Ask : 221.20p |
| High Today : 222.00p | Low Today : 219.90p |
| This Years High : 293.40p | This Years Low : 213.40p |
| Volume : 202,887 | MKT Cap : £4532.39M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Convatec Group (CTEC) Overview
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Based in Reading, it employs over 9,000 people in more than 100 countries.Convatec Group (CTEC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Overweight | Barclays | Premium Only | 2024-12-20 06:26:00 20/12/2024 | -0.18% |
| Overweight | Barclays | Premium Only | 2024-11-21 07:44:00 21/11/2024 | -5.15% |
| Buy | Jefferies | Premium Only | 2024-11-14 04:47:00 14/11/2024 | -13.25% |
| Overweight | Barclays | Premium Only | 2024-11-13 05:38:00 13/11/2024 | -16.21% |
| Overweight | JP Morgan | Premium Only | 2024-11-13 04:53:00 13/11/2024 | -16.21% |
Convatec Group (CTEC) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Balyasny Asset Management (UK) LLP | 0.54% | 05/09/2024 |
| AKO Capital LLP | 0.54% | 16/05/2024 |
| Latest Bid : 220.80p | Latest Ask : 221.20p |
| High Today : 222.00p | Low Today : 219.90p |
| This Years High : 293.40p | This Years Low : 213.40p |
| Volume : 202,887 | MKT Cap : £4532.39M |
Convatec Group Overview
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Based in Reading, it employs over 9,000 people in more than 100 countries.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Convatec Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Overweight | Barclays | Premium Only | 2024-12-20 06:26:00 20/12/2024 | -0.18% |
| Overweight | Barclays | Premium Only | 2024-11-21 07:44:00 21/11/2024 | -5.15% |
| Buy | Jefferies | Premium Only | 2024-11-14 04:47:00 14/11/2024 | -13.25% |
| Overweight | Barclays | Premium Only | 2024-11-13 05:38:00 13/11/2024 | -16.21% |
| Overweight | JP Morgan | Premium Only | 2024-11-13 04:53:00 13/11/2024 | -16.21% |